Works matching IS 03065251 AND DT 2018 AND VI 84 AND IP 7
Results: 31
Issue highlights.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1397, doi. 10.1111/bcp.13654
- Publication type:
- Article
Gjestad et al. reply to ‘Was 4β‐hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?’ by Neuhoff and Tucker.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta‐analysis.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1445, doi. 10.1111/bcp.13604
- By:
- Publication type:
- Article
The clinical utility of pharmacometric models.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1413, doi. 10.1111/bcp.13603
- By:
- Publication type:
- Article
Annotated guidance to the European Medicines Agency (EMA) guidelines and regulatory documents. A new series of the BJCP.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1399, doi. 10.1111/bcp.13599
- By:
- Publication type:
- Article
Reducing potentially inappropriate drug prescribing in nursing home residents: effectiveness of a geriatric intervention.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1598, doi. 10.1111/bcp.13598
- By:
- Publication type:
- Article
Population pharmacokinetics of voriconazole and CYP2C19 polymorphisms for optimizing dosing regimens in renal transplant recipients.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1587, doi. 10.1111/bcp.13595
- By:
- Publication type:
- Article
Drug induced liver injury with analysis of alternative causes as confounding variables.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1467, doi. 10.1111/bcp.13593
- By:
- Publication type:
- Article
Kuypers and Vanhove reply to ‘Was 4β‐hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?’ by Neuhoff and Tucker.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
A pharmacological rationale for improved everolimus dosing in oncology and transplant patients.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1575, doi. 10.1111/bcp.13591
- By:
- Publication type:
- Article
The relationship between frailty and polypharmacy in older people: A systematic review.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1432, doi. 10.1111/bcp.13590
- By:
- Publication type:
- Article
Oleuropein, a component of extra virgin olive oil, lowers postprandial glycaemia in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1566, doi. 10.1111/bcp.13589
- By:
- Publication type:
- Article
Evident bias in a paracetamol metabolite population pharmacokinetic model applied to an external dataset.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
An update on the clinical evidence that supports biosimilar approvals in Europe.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1415, doi. 10.1111/bcp.13586
- By:
- Publication type:
- Article
Model‐based dosing with concentration feedback as an integral part of personalized hydroxycarbamide management.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1410, doi. 10.1111/bcp.13585
- By:
- Publication type:
- Article
First‐in‐man–proof of concept study with molidustat: a novel selective oral HIF‐prolyl hydroxylase inhibitor for the treatment of renal anaemia.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1557, doi. 10.1111/bcp.13584
- By:
- Publication type:
- Article
Recurrent coronary disease in HIV‐infected patients: role of drug–drug interactions.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1617, doi. 10.1111/bcp.13583
- By:
- Publication type:
- Article
Antibiotics and risk for birth defects.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Preventability of serious thromboembolic and bleeding events related to the use of oral anticoagulants: a prospective study.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1544, doi. 10.1111/bcp.13580
- By:
- Publication type:
- Article
The effects of the selective muscarinic M3 receptor antagonist darifenacin, and of hyoscine (scopolamine), on motion sickness, skin conductance & cognitive function.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1535, doi. 10.1111/bcp.13579
- By:
- Publication type:
- Article
Can H<sub>2</sub>‐receptor upregulation and raised histamine explain an anaphylactoid reaction on cessation of ranitidine in a 19‐year‐old female? A case report.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1611, doi. 10.1111/bcp.13578
- By:
- Publication type:
- Article
Full covariate modelling approach in population pharmacokinetics: understanding the underlying hypothesis tests and implications of multiplicity.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1525, doi. 10.1111/bcp.13577
- By:
- Publication type:
- Article
Does patient reporting lead to earlier detection of drug safety signals? A retrospective comparison of time to reporting between patients and healthcare professionals in a global database.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1514, doi. 10.1111/bcp.13576
- By:
- Publication type:
- Article
Use of attention‐deficit/hyperactivity disorder medication among older adults in Denmark.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1505, doi. 10.1111/bcp.13569
- By:
- Publication type:
- Article
Incorporation of GSTA1 genetic variations into a population pharmacokinetic model for IV busulfan in paediatric hematopoietic stem cell transplantation.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1494, doi. 10.1111/bcp.13566
- By:
- Publication type:
- Article
Clinical safety, tolerability, pharmacokinetics and effects on urinary electrolyte excretion of AZD9977, a novel, selective mineralocorticoid receptor modulator.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1486, doi. 10.1111/bcp.13562
- By:
- Publication type:
- Article
Commentary on the EMA Guideline on strategies to identify and mitigate risks for first‐in‐human and early clinical trials with investigational medicinal products.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1401, doi. 10.1111/bcp.13550
- By:
- Publication type:
- Article
Was 4β‐hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Integrating data from the Investigational Medicinal Product Dossier/investigator's brochure. A new tool for translational integration of preclinical effects.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1457, doi. 10.1111/bcp.13529
- By:
- Publication type:
- Article
Hydroxycarbamide in children with sickle cell anaemia after first‐dose vs. chronic therapy: pharmacokinetics and predictive models for drug exposure.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1478, doi. 10.1111/bcp.13426
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1395, doi. 10.1111/bcp.13413
- Publication type:
- Article